Polycaprolactone Bone Augmentation Crystalline Skin
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone augmentation and fixation methods, such as PMMA and calcium phosphate cements, face challenges in osteoporotic bone due to lack of stability, excess stress, and limited mechanical properties, making it difficult to achieve effective load transfer and bone reconstruction, especially in areas like the proximal humerus and vertebral bodies.
Innovation Solution
A method involving thermoplastic materials, specifically polycaprolactone (PCL), which is introduced in a flowable state and treated to form a crystalline skin that expands, providing a semi-solid structure for improved bone augmentation and fixation, allowing for better control and reduced extravasation, while matching the modulus of cancellous bone for stress distribution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PMMA cement is used for bone augmentation, then screw fixation stability is improved, but stress concentration at bone interface increases and material remains permanently in body
Solution Approach 1:
The patent changes the material parameters by using thermoplastic polymers with tunable mechanical properties that match cancellous bone modulus, rather than the fixed high-stiffness PMMA. This allows the augmentation material to have comparable strength to bone while avoiding excessive stress concentration at the bone interface.
Solution Approach 2:
The patent employs composite thermoplastic materials combining polymer matrices with bone-like particulate phases, creating a composite that mimics the mechanical behavior of natural bone. This composite structure provides both the needed fixation stability and stress distribution characteristics.
2Stability of the object's composition
If calcium phosphate cement is used for bone augmentation, then bone remodeling is enabled, but material lacks sufficient mechanical strength and ductility
Solution Approach 1:
The patent creates composite thermoplastic materials that combine the ductility and strength of polymers with the bone-like characteristics of particulate phases. This composite approach achieves both adequate mechanical strength and bone remodeling capability through osteoconductive surfaces.
Solution Approach 2:
The patent utilizes porous structures within the thermoplastic augmentation material to facilitate bone ingrowth and remodeling while maintaining sufficient mechanical integrity. The porous architecture allows cellular infiltration and new bone formation without compromising the material's load-bearing capacity.
3Ease of operation
If thermoplastic material is injected in flowable state, then control of implantation direction is improved, but material must be heated above melting point
Solution Approach 1:
The patent utilizes the temperature-dependent rheological properties of thermoplastic materials, transitioning from solid to flowable state through controlled heating above melting point, then allowing recrystallization upon cooling to achieve the desired shape and position within the bone defect.
4Strength
If augmentation material is too stiff, then screw fixation is strengthened, but stress shielding and interface stress increase
Solution Approach 1:
The patent adjusts the mechanical parameters of the augmentation material to match the modulus of cancellous bone, creating a stress-distributing interface that prevents both stress shielding and excessive stress concentration, while still providing adequate screw fixation strength.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PCL-based method enhances bone augmentation by providing a cohesive, shape-retentive material that reduces stress at the bone interface, improves screw fixation, and allows for controlled injection and manipulation, addressing the limitations of existing materials in osteoporotic bone environments.
Implementation Method 1
heating the mass of irradiated polycaprolactone above its melting temperature
Implementation Method 2
allowing the mass of polycaprolactone to return to a shape that approaches the first shape
Data Source
AI summary
A method for augmenting a tissue including introducing into the tissue a first thermoplastic material at a first condition; treating the first thermoplastic material to achieve a second condition that includes an at least partially crystalline skin; and introducing a second material into the tissue whereby the first thermoplastic material and the second material are contained by the at least partially crystalline skin. Also a method of fracture reduction in a tissue including exposing to gamma radiation a mass of polycaprolactone characterized by a first shape; heating the mass of irradiated polycaprolactone above its melting temperature; introducing the heated mass of polycaprolactone into the tissue annulus to deform it from the first shape; allowing the material to return to the first shape.